Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Qualio Reviews & Ratings
    4.4 out of 5 stars 919 Ratings
    Company Website for Qualio
  • RXNT Reviews & Ratings
    4.3 out of 5 stars 552 Ratings
    Company Website for RXNT
  • AdvancedMD Reviews & Ratings
    5.0 out of 5 stars 2 Ratings
    Company Website for AdvancedMD
  • Lockbox LIMS Reviews & Ratings
    4.8 out of 5 stars 72 Ratings
    Company Website for Lockbox LIMS
  • QBench Reviews & Ratings
    4.6 out of 5 stars 153 Ratings
    Company Website for QBench
  • Aesthetic Insight Reviews & Ratings
    5.0 out of 5 stars 10 Ratings
    Company Website for Aesthetic Insight
  • Elation Health Reviews & Ratings
    4.1 out of 5 stars 90 Ratings
    Company Website for Elation Health
  • DoctorConnect Reviews & Ratings
    4.7 out of 5 stars 85 Ratings
    Company Website for DoctorConnect
  • Jama Connect Reviews & Ratings
    4.3 out of 5 stars 416 Ratings
    Company Website for Jama Connect
  • Couchbase Reviews & Ratings
    4.4 out of 5 stars 418 Ratings
    Company Website for Couchbase

What is Saama?

Utilizing actionable insights from a top-tier AI-powered clinical analytics platform empowers your teams to adeptly navigate risks and improve performance across studies, systems, sites, and vendor interactions. The innovative technology developed by Saama is designed to streamline workflows, automate tedious tasks, and enhance collaboration among diverse clinical functions including operations, medical review, data management, biostatistics, and pharmacovigilance. Both sponsors and contract research organizations (CROs) rely on Saama's robust data aggregation and AI capabilities, which support better decision-making, reduce delays, and significantly lower costs and timelines associated with the drug development process. By implementing Saama's solutions, you can hasten the advancement of clinical trial innovation. Centralizing and continuously updating your clinical data greatly simplifies the work of your ClinOps and medical review teams. In addition, Data Managers, who are often overlooked, can redirect their attention from mundane tasks to the essential data points that are critical for project success, thereby ensuring their skills are effectively utilized. This shift not only improves operational efficiency but also plays a vital role in enhancing the quality of clinical outcomes, ultimately contributing to more successful trials and better patient care. Embracing these advancements is imperative for organizations aiming to stay competitive in the ever-evolving landscape of drug development.

What is OpenText for Life Sciences?

OpenTextâ„¢ Information Management solutions provide life sciences organizations with the tools needed to leverage data and content insights, improving their decision-making processes and accelerating product development timelines. These solutions facilitate the smooth integration, management, and secure exchange of information across individuals, systems, and devices. By optimizing the use of information assets from research and development to commercialization, companies can take advantage of flexible cloud-native software that functions seamlessly in various environments. OpenText specifically tailored for the life sciences sector greatly speeds up the discovery phase, enabling the extraction of actionable insights that drive innovation throughout the development pipeline. Users can transform research articles into electronic lab notebooks via intelligent capture and harness text mining techniques to reveal valuable insights. Furthermore, the platform excels in extracting knowledge from unstructured text found in clinical trial reports, study protocols, and data pertaining to clinical safety and efficiency. It also provides tools for the intelligent analysis, categorization, and extraction of information from clinical trial documents, thereby reducing the likelihood of costly delays and disruptions in the development process. By harnessing these advanced features, life sciences organizations can significantly improve their operational efficiency and propel their research initiatives forward while remaining competitive in a fast-evolving field. The integration of these tools ultimately enhances collaboration and innovation across the entire organization.

Media

Media

Integrations Supported

Integrations Supported

Amazon Web Services (AWS)
Google Cloud Platform
Microsoft 365
Oracle Cloud Infrastructure
SAP Cloud Platform
SAP HANA
SAP S/4HANA
Salesforce

API Availability

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Documentation Hub
Webinars
On-Site Training

Training Options

Documentation Hub
Webinars
On-Site Training

Company Facts

Organization Name

Saama

Date Founded

2011

Company Location

United States

Company Website

www.saama.com

Company Facts

Organization Name

OpenText

Company Location

Canada

Company Website

www.opentext.com/products-and-solutions/industries/life-sciences

Categories and Features

Categories and Features

Popular Alternatives

Popular Alternatives

Clienvo eTMF Reviews & Ratings

Clienvo eTMF

Clinevo
5.0 out of 5 stars
Medidata Reviews & Ratings

Medidata

Dassault Systèmes
RIMTrack Reviews & Ratings

RIMTrack

WinWire Technologies
Fusion eClinical Suite Reviews & Ratings

Fusion eClinical Suite

Axiom Real-Time Metrics
Datatrak Reviews & Ratings

Datatrak

Datatrak International, Inc.